A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)

Clinical trial NCT05143177 · TERMINATED

Trial details

NCT number: NCT05143177
Sponsor: REDNVIA Co., Ltd.
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Calcific Aortic Valve Disease

Start date: 2022-06-27
Primary completion: 2026-03-21
Enrollment: 486

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.